セッション情報

一般演題 (示説)

第54回・2016年・横浜
一般演題 (示説)
示説 (Poster) 25
International Poster 1
開催回
第54回・2016年・横浜

Pharmacokinetic similarity of ABP 980 relative to trastuzumab in the Japanese subset: Results from a randomized, single-blind, single-dose, parallel group study in healthy subjects

演題番号 : P25-1

Hanes Vladimir:1、Chow Vincent:1、Zhang Nan:1、Markus Richard:1

1:Amgen, USA・Biosimilars

Pharmacokinetic similarity of ABP 980 relative to trastuzumab in the Japanese subset: Results from a randomized, single-blind, single-dose, parallel group study in healthy subjects

UBE2 inhibitor NSC697923 overcomes HIF-1alpha-induced radiation resistance in colorectal cancer

演題番号 : P25-2

Gombodorj Navchaa:1,4、Yokobori Takehiko:2、Yoshiyama Shinji:3、Kawabata Reika:3、Rokudai Susumu:2、Nishiyama Masahiko:2、Nakano Takashi:1,5

1:Gunma University Graduate School of Medicine・Department of Radiation Oncology、2:Gunma University Graduate School of Medicine・Molecular Pharmacology and Oncology、3:Gunma University Initiative for Advanced Research (GIAR)・Research Program for Omics-based Medical Science・Integrated Oncology Research、4:National Cancer Center of Mongolia・Radiation Oncology、5:Gunma University Heavy Ion Medical Center

UBE2 inhibitor NSC697923 overcomes HIF-1alpha-induced radiation resistance in colorectal cancer

The expression and function of L1CAM in cervical cancer--promotes tumor progression and is an independent unfavorable prognostic factor

演題番号 : P25-3

Jue Zhang:1、Xufeng Wu:1

1:Hubei Maternal and Child hospital, China・Gynecologic Oncology

The expression and function of L1CAM in cervical cancer--promotes tumor progression and is an independent unfavorable prognostic factor

Oral glutamine supplementation in prevention of radiotherapy-induced esophagitis in advanced non-small cell lung cancer patients

演題番号 : P25-4

Chang Chang Yu:1、Chang Shih-chieh:1

1:Far Eastern Memorial Hospital, New Taipei City, Taiwan・Internal Medicine・Chest Medicine

Oral glutamine supplementation in prevention of radiotherapy-induced esophagitis in advanced non-small cell lung cancer patients

Phase 2 study of irinotecan plus panitumumab as 2nd-line therapy for esophageal adenocarcinoma(EAC): Update of survival and correlative biomarkers

演題番号 : P25-5

Gibson Michael K.:1、Karapetyan Lilit:1、Fu Pingfu:1、Kresak Adam:1

1:Case Western Reserve University, USA・Medical Oncology・Medicine

Phase 2 study of irinotecan plus panitumumab as 2nd-line therapy for esophageal adenocarcinoma(EAC): Update of survival and correlative biomarkers

LOXL2 is required for EMT and migration in pancreas cancer

演題番号 : P25-6

Park Joon Seong:1、Lee Yun Sun:1、Yoon Dong Sup:1

1:Yonsei University College of Medicine, China・Department of Surgery

LOXL2 is required for EMT and migration in pancreas cancer

Patterns of metastases and Second Primary Malignancies (SPM) in patients with invasive Transitional Cell Carcinoma (TCC) of the bladder

演題番号 : P25-7

Mermershtain Wilmosh:1、Gusakova Irina:1、Shiyovich Artur:1、Ariad Samuel:1、Rouvinov Keren:1

1:Soroka University Medical Center, Israel・Department of Oncology・Onco-Urology Service

Patterns of metastases and Second Primary Malignancies (SPM) in patients with invasive Transitional Cell Carcinoma (TCC) of the bladder

Efficacy and safety of tadalafil (CIALIS) in men with erectile dysfunction secondary to radical prostatectomy or hormone-radiotherapy in patients with prostate cancer

演題番号 : P25-8

Mermershtain Wilmosh:1、Mashal Abdallah:2、Gusakova Irina:1、Ariad Samuel:1、Keren Rouvinov:1

1:Soroka University Medical Center, Israel・Department of Oncology・Onco - Urology Service、2:Soroka University Medical Center・Department of Family Medicine

Efficacy and safety of tadalafil (CIALIS) in men with erectile dysfunction secondary to radical prostatectomy or hormone-radiotherapy in patients with prostate cancer

Watchful Waiting (WW) in localized prostate cancer: A single institution experience

演題番号 : P25-9

Mermershtain Wilmosh:1、Ariad Samuel:1、Rouvinov Keren:1

1:Soroka University Medical Center, Israel・Department of Oncology・Onco - Urology Service

Watchful Waiting (WW) in localized prostate cancer: A single institution experience

An impact of pelvic magnetic resonance imaging to radiotherapy volume definition in patients with intermediate- and high-risk prostate cancer: A Population based study

演題番号 : P25-10

Mermershtain Wilmosh:1、Rouvinov Keren:1、Belochitski Olga:1、Keizman Daniel:2、Ariad Samuel:1、Lavrenkov Konstantin:1

1:Soroka University Medical Center, Israel・Department of Oncology・Onco - Urology Service、2:Meir Medical Center・Department of Oncology・Onco - Urology Service

An impact of pelvic magnetic resonance imaging to radiotherapy volume definition in patients with intermediate- and high-risk prostate cancer: A Population based study

Tumor responses following a switch from non-steroidal (bicalutamide) to steroidal (cyproterone acetat) antiandrogen deprivation therapy

演題番号 : P25-11

Mermershtain Wilmosh:1、Ariad Samuel:1、Rouvinov Keren:1

1:Soroka University Medical Center, Israel・Department of Oncology・Onco-Urology Service

Tumor responses following a switch from non-steroidal (bicalutamide) to steroidal (cyproterone acetat) antiandrogen deprivation therapy